NovoCure Limited Stock Deutsche Boerse AG
Stocks
038
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.60 EUR | -2.51% |
|
-2.40% | +24.04% |
| 06-30 | NovoCure Says Optune Pax Receives CE Mark for Locally Advanced Pancreatic Cancer Treatment | MT |
| 06-29 | NovoCure Limited(NasdaqGS:NVCR) added to Russell 2000 Value Benchmark | CI |
| Market Cap | 1.85B 1.62B 1.5B 1.38B 2.6B 178B 2.64B 17.89B 7.01B 87.11B 6.93B 6.78B 300B | P/E 2026 * |
-10x | P/E 2027 * | -15x |
|---|---|---|---|---|---|
| Enterprise Value | 1.64B 1.44B 1.33B 1.22B 2.3B 158B 2.34B 15.87B 6.22B 77.27B 6.15B 6.02B 266B | EV / Sales 2026 * |
2.31x | EV / Sales 2027 * | 1.93x |
| Free-Float |
89.99% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NovoCure Limited
| 1 day | -2.51% | ||
| 1 week | -2.40% | ||
| Current month | -2.47% | ||
| 1 month | +12.73% | ||
| 3 months | +28.98% | ||
| 6 months | +21.87% | ||
| Current year | +24.04% |
| 1 week | 13.3 |  | 13.94 |
| 1 month | 11.58 | | 15.2 |
| Current year | 8.12 | | 16.55 |
| 1 year | 8.12 | | 16.55 |
| 3 years | 8.12 | | 35.87 |
| 5 years | 8.12 | | 161.9 |
| 10 years | 5.18 | | 203.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Frank Leonard
CEO | Chief Executive Officer | 46 | 01/12/2025 |
| Director of Finance/CFO | 52 | 01/01/2025 | |
Moshe Giladi
CTO | Chief Tech/Sci/R&D Officer | - | 17/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Asaf Danziger
BRD | Director/Board Member | 59 | 01/01/2012 |
Bill Doyle
CHM | Chairman | 63 | 01/01/2009 |
Kin Yip Leung
BRD | Director/Board Member | 64 | 05/08/2011 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.51% | -2.40% | - | - | 1.84B | |
| -0.10% | -0.29% | +38.04% | +3.97% | 12.52B | |
| -0.22% | +10.37% | +15.54% | +20.68% | 6.57B | |
| -0.25% | -2.15% | +58.98% | +26.84% | 5.83B | |
| -0.06% | +5.09% | - | - | 4.75B | |
| +7.86% | +6.28% | -24.06% | +26.14% | 4.25B | |
| +1.80% | +5.55% | -20.95% | -20.32% | 4.02B | |
| -1.63% | -5.33% | -6.07% | +253.63% | 1.8B | |
| +1.15% | +2.33% | +61.68% | -2.22% | 1.56B | |
| -1.19% | -0.37% | -20.98% | -47.98% | 1.28B | |
| Average | +0.46% | +2.17% | +12.77% | +32.59% | 4.73B | |
| Weighted average by Cap. | +0.64% | +3.08% | +21.00% | +20.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 708M 621M 574M 528M 995M 68.28B 1.01B 6.86B 2.69B 33.41B 2.66B 2.6B 115B | 790M 693M 640M 589M 1.11B 76.2B 1.13B 7.66B 3B 37.28B 2.97B 2.9B 128B |
| Net income | -182M -160M -148M -136M -256M -17.58B -260M -1.77B -692M -8.6B -684M -670M -29.63B | -119M -104M -96.08M -88.37M -167M -11.44B -169M -1.15B -450M -5.6B -445M -436M -19.28B |
| Net Debt | -209M -183M -169M -155M -293M -20.11B -298M -2.02B -792M -9.84B -783M -766M -33.9B | -317M -278M -257M -236M -446M -30.59B -453M -3.07B -1.2B -14.97B -1.19B -1.17B -51.56B |
| Date | Price | Change |
|---|---|---|
| 20/07/26 | €13.60 | -2.51% |
| 17/07/26 | €13.95 | +1.94% |
| 16/07/26 | €13.68 | +2.82% |
| 15/07/26 | €13.31 | -3.66% |
| 14/07/26 | €13.81 | -0.86% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NVCR Stock
- 038 Stock
Select your edition
All financial news and data tailored to specific country editions
